Impact BioMedical Inc.

NYSEAM:IBO Stock Report

Market Cap: US$13.3m

Impact BioMedical Past Earnings Performance

Past criteria checks 3/6

Impact BioMedical's earnings have been declining at an average annual rate of -33.9%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 20.1% per year.

Key information

-33.9%

Earnings growth rate

-33.0%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate20.1%
Return on equity3.2%
Net Marginn/a
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Impact BioMedical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSEAM:IBO Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240120
30 Jun 240-421
31 Mar 240-521
31 Dec 230-421
30 Sep 230-612
30 Jun 230-811
31 Mar 230-711
31 Dec 220-711
30 Sep 220-311
30 Jun 220-211
31 Mar 220-111
31 Dec 210-111
30 Sep 210-211
30 Jun 210-111
31 Mar 210-111
31 Dec 200-101
30 Sep 200-100
31 Mar 200000
31 Dec 190000

Quality Earnings: IBO has high quality earnings.

Growing Profit Margin: IBO became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: IBO has become profitable over the past 5 years, growing earnings by -33.9% per year.

Accelerating Growth: IBO has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: IBO has become profitable in the last year, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (54.6%).


Return on Equity

High ROE: IBO's Return on Equity (3.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 21:33
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Impact BioMedical Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution